Latest filing published 27 Dec 2011 for Lexicon Pharmaceuticals, INC., €98.3M.
Insider track record
No signal scores available.
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +28.5%Entry US$9.59 · Close at T+365 US$12.32
- +5.3%Entry US$11.90 · Close at T+365 US$12.53
- -39.2%Entry US$14.84 · Close at T+365 US$9.03
- -40.5%Entry US$22.47 · Close at T+365 US$13.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ulys, LLC: trading record in brief
Ulys, LLC appears in our data through filings on Lexicon Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 24 August 2007 to 22 December 2011, the count stands at 11 filings.
The open-market record is one-sided, with 9 purchases worth €246.8M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants.
The median purchase comes to €13.5M. For 9 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -1.5%. These figures describe past trades and do not predict future prices.
The newest entry dates from 27 December 2011: a share grant of €98.3M, in Lexicon Pharmaceuticals, Inc. The last insider purchase was made public on 19 March 2010, 6,079 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ulys, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 113,382,063 shares@ US$1.13Common StockSEC:0001209191-11-063163:0
- 1,622,184 shares@ US$1.13Common StockSEC:0001209191-11-063163:1
- 59,296,749 shares@ US$1.15Common StockSEC:0001181431-10-017475:0Canonical exit: 17 Jun 2010 (T+90)
- 5,190,848 shares@ US$1.15Common StockSEC:0001181431-10-017475:1Canonical exit: 17 Jun 2010 (T+90)
- 29,021,739 shares@ US$1.15Common StockSEC:0001181431-10-017475:2Canonical exit: 17 Jun 2010 (T+90)
- 760,870 shares@ US$1.15Common StockSEC:0001181431-10-017475:3Canonical exit: 17 Jun 2010 (T+90)
- 13,439,257 shares@ US$1.50Common StockSEC:0001181431-09-047797:0Canonical exit: 12 Jan 2010 (T+90)
- 2,015,888 shares@ US$1.50Common StockSEC:0001181431-09-047797:1Canonical exit: 13 Jan 2010 (T+90)
- 669,052 shares@ US$2.00Common StockSEC:0001181431-08-028285:0Canonical exit: 29 Jul 2008 (T+90)
- 16,499,347 shares@ US$3.0915Common StockSEC:0001181431-07-054077:0Canonical exit: 22 Nov 2007 (T+90)
- 34,325,639 shares@ US$4.50Common StockSEC:0001181431-07-054077:1Canonical exit: 22 Nov 2007 (T+90)
11 of 11 declarations